McKesson Debt to Equity Ratio 2010-2024 | MCK

Current and historical debt to equity ratio values for McKesson (MCK) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. McKesson debt/equity for the three months ending March 31, 2024 was 0.00.
McKesson Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-03-31 $69.04B $-1.60B -43.18
2023-12-31 $68.19B $-1.68B -40.54
2023-09-30 $67.56B $-1.46B -46.14
2023-06-30 $65.34B $-1.24B -52.69
2023-03-31 $63.81B $-1.49B -42.83
2022-12-31 $64.78B $-2.09B -31.01
2022-09-30 $64.33B $-1.25B -51.51
2022-06-30 $63.77B $-1.47B -43.32
2022-03-31 $65.09B $-1.79B -36.32
2021-12-31 $64.50B $-0.79B -81.95
2021-09-30 $63.69B $-0.09B -732.05
2021-06-30 $62.94B $-0.05B -1398.64
2021-03-31 $64.84B $0.18B 370.51
2020-12-31 $62.12B $-0.28B -224.27
2020-09-30 $55.47B $6.09B 9.11
2020-06-30 $52.01B $5.65B 9.20
2020-03-31 $55.94B $5.31B 10.54
2019-12-31 $54.49B $6.39B 8.53
2019-09-30 $52.30B $6.69B 7.82
2019-06-30 $53.61B $8.07B 6.65
2019-03-31 $51.39B $8.29B 6.20
2018-12-31 $51.62B $9.39B 5.50
2018-09-30 $51.89B $9.53B 5.44
2018-06-30 $51.64B $9.65B 5.35
2018-03-31 $50.32B $10.06B 5.00
2017-12-31 $52.24B $11.97B 4.36
2017-09-30 $52.48B $11.36B 4.62
2017-06-30 $50.30B $11.51B 4.37
2017-03-31 $49.70B $11.27B 4.41
2016-12-31 $50.02B $7.85B 6.37
2016-09-30 $48.69B $9.62B 5.06
2016-06-30 $48.41B $9.49B 5.10
2016-03-31 $47.52B $9.01B 5.28
2015-12-31 $46.13B $8.96B 5.15
2015-09-30 $46.95B $8.87B 5.29
2015-06-30 $46.99B $8.94B 5.26
2015-03-31 $45.79B $8.09B 5.66
2014-12-31 $45.95B $9.16B 5.02
2014-09-30 $41.71B $10.53B 3.96
2014-06-30 $42.24B $10.77B 3.92
2014-03-31 $41.44B $10.32B 4.02
2013-12-31 $28.45B $8.03B 3.55
2013-09-30 $27.96B $7.99B 3.50
2013-06-30 $28.08B $7.41B 3.79
2013-03-31 $27.72B $7.07B 3.92
2012-12-31 $25.78B $7.65B 3.37
2012-09-30 $25.25B $7.72B 3.27
2012-06-30 $24.55B $7.20B 3.41
2012-03-31 $26.26B $6.83B 3.85
2011-12-31 $25.70B $7.46B 3.45
2011-09-30 $24.79B $7.12B 3.48
2011-06-30 $24.10B $6.92B 3.48
2011-03-31 $23.67B $7.22B 3.28
2010-12-31 $23.32B $7.08B 3.29
2010-09-30 $19.98B $6.82B 2.93
2010-06-30 $20.52B $6.88B 2.98
2010-03-31 $20.66B $7.53B 2.74
2009-12-31 $20.42B $7.12B 2.87
2009-09-30 $19.91B $6.72B 2.96
2009-06-30 $19.45B $6.27B 3.10
2009-03-31 $19.07B $6.19B 3.08
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $72.887B $308.951B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $66.122B 18.71
West Pharmaceutical Services (WST) United States $24.159B 43.30
Cardinal Health (CAH) United States $23.477B 13.43
Align Technology (ALGN) United States $19.244B 37.15
Cooper (COO) United States $18.860B 28.54
Labcorp (LH) United States $16.830B 14.49
Henry Schein (HSIC) United States $9.184B 16.34
DENTSPLY SIRONA (XRAY) United States $5.702B 14.76
Merit Medical Systems (MMSI) United States $4.760B 26.09
CONMED (CNMD) United States $2.281B 20.69
Patterson (PDCO) United States $2.145B 10.27
STAAR Surgical (STAA) United States $2.022B 77.66
Atrion (ATRI) United States $0.815B 43.51
Lifevantage (LFVN) United States $0.096B 12.34
Pro-Dex (PDEX) United States $0.067B 34.03
Biolase (BIOL) United States $0.006B 0.00